Tonix Pharmaceuticals (TNXP) stock gains as the company posts peer-reviewed data for pain drug TNX-102 and new data for mpox ...

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) saw its stock rise 2% after unveiling new preclinical findings for its ...

Tonix Pharmaceuticals (NASDAQ: TNXP) , a fully integrated biopharmaceutical company, announced that Dr. Sina Bavari, Executive Vice President of Infe ...

Single dose vaccination with TNX-801 protects animals from a lethal challenge with monkeypox, the causative agent of mpox TNX ...

Market is projected to grow at a CAGR of 5% through 2029, fueled by rising R&D costs, declining pharmaceutical sales, growing ...

Tonix Pharmaceuticals (NASDAQ: TNXP) , a fully integrated biotech company, announced its inclusion in the Russell 3000® and Russell 2000® Indexes fol ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biotechnology company, today ...

Tonix Pharmaceuticals Holding Corp. detailed financials by Barron's. View TNXP business summary and company performance, for a clear financial breakdown.

Get the latest (TONIX) stock news and headlines to help you in your trading and investing decisions.

UCB’s Fintepla has been approved to treat seizures associated with two epilepsy disorders and now has posted data that could pave the way for its use in another epilepsy condition.

“Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stock gained on optimism for the launch of its new drug Journavx, a non-opioid painkiller for acute pain and the first new class of pain ...

Sun Pharma appoints Richard Ascroft as North America CEO to lead U.S. and Canada operations, including new drug launches and NJ HQ expansion.